compounded semaglutide lawsuit update Hims & Hers Health (HIMS) Securities Class Action Novo Nordisk expands lawsuits against

MIAMI For patients with idiopathic intracranial hypertension, GLP-1 receptor agonists may help with weight loss and play a role in reducing intracranial pressure, according to a speaker at Sunshine Eye & Retina

The company is positioning the KwikPen at $299 per month for self-pay patients through its direct-to-consumer channel, LillyDirect, which is meant to reduce the friction and cost surprises that can come with traditional pharmacy routes

Last month, CVS Caremark announced that it had struck a deal to make Novo's Wegovy its primary weight loss drug starting in the second half of the year, which would mean coverage for Lilly's Zepbound would no longer be preferred

2024;[Epub ahead of print]

The medication may have lost some potency

If the lines are reversed (the return limb is used to access the patient's blood), the access tubing will be connected to the return limb of the patient's catheter